Evidence map›Paper›PMID 32574271›Full record

ArticleFrontiers in immunology2020

The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria.

Douglas B Kell, Eugene L Heyden, Etheresia Pretorius

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06232642 (The Effects of Lactoferrin and Iron-enriched Whey on Iron Status of Active Collegiate Females), which is not on this map. Cited by 235 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
235citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06232642 naunknown statusnot on this mapstarted 2024, after this paper: background citation

The Effects of Lactoferrin and Iron-enriched Whey on Iron Status of Active Collegiate Females

TypeinterventionalSponsorUtah State UniversityRan2024 to 2025Enrolled82ConditionsSerum FerritinArmsLactoferrin, iron and B12 in Whey Protein, Lactoferrin, Iron and B12 in Rice Protein, Lactoferrin, Iron and B12 in Maltrodextrin
3 · Its place in the literature

Who cites it

235 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Iron and the lung: emerging roles of iron metabolism in pulmonary disease pathogenesis and therapy.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

175 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Douglas B KellDepartment of Biochemistry, Faculty of Health and Life Sciences, Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Eugene L HeydenRetired, Spokane, WA, United States.
Etheresia PretoriusDepartment of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactoferrin is a nutrient classically found in mammalian milk. It binds iron and is transferred via a variety of receptors into and between cells, serum, bile, and cerebrospinal fluid. It has important immunological properties, and is both antibacterial and antiviral. In particular, there is evidence that it can bind to at least some of the receptors used by coronaviruses and thereby block their entry. Of importance are Heparan Sulfate Proteoglycans (HSPGs) and the host receptor angiotensin-converting enzyme 2 (ACE2), as based on other activities lactoferrin might prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from attaching to the host cells. Lactoferrin (and more specifically enteric-coated LF because of increased bioavailability) may consequently be of preventive and therapeutic value during the present COVID-19 pandemic.

Indexed as

Angiotensin-Converting Enzyme 2AnimalsAnti-Bacterial AgentsBacterial InfectionsDietary SupplementsHeparan Sulfate ProteoglycansHumansLactoferrinPeptidyl-Dipeptidase AReceptors, Cell SurfaceReceptors, CoronavirusReceptors, VirusVirus DiseasesACE2 protein, humanAngiotensin-Converting Enzyme 2Anti-Bacterial AgentsHeparan Sulfate ProteoglycansLactoferrinlactoferrin receptorsPeptidyl-Dipeptidase AReceptors, Cell SurfaceReceptors, CoronavirusReceptors, ViruscoronavirusesHSPGsironlactoferrinmembrane receptors

Identifiers

PMID32574271
PMCPMC7271924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.